| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/29/2009 | WO2009013503A1 Method and apparatus for monitoring offshore contamination |
| 01/29/2009 | WO2009013370A1 Biosensors based on microalgae for detection of environmental pollutants |
| 01/29/2009 | WO2009013360A1 Novel fluorescent derivatives of polyamine, method for preparing same and applications thereof as diagnosis tools in the treatment of cancerous tumours |
| 01/29/2009 | WO2009013352A1 Native gp41 assay |
| 01/29/2009 | WO2009013350A2 Imaging medium comprising hyperpolarised 13 c-lactate and use thereof |
| 01/29/2009 | WO2009013319A1 Screening, therapy and diagnosis |
| 01/29/2009 | WO2009013254A1 A novel population of hepatocytes derived via definitive endoderm (de-hep) from human blastocysts stem cells |
| 01/29/2009 | WO2009013075A2 Markers for invasion in breast and lung carcinoma |
| 01/29/2009 | WO2009013053A1 Combined method and kit for the sequential measurement of (1) the enzymatically active fraction and (2) the total amount of an enzyme |
| 01/29/2009 | WO2009012773A1 Soluble cadherin 17 for the diagnosis and risk stratification of cancer and tumour of the gastrointestinal tract |
| 01/29/2009 | WO2009012708A1 A method for diagnosing bladder cancer by analyzing dna methylation profiles in urine sediments and its kit |
| 01/29/2009 | WO2009012595A1 Methods for the diagnosis, risk assessment, and monitoring of autism spectrum disorders |
| 01/29/2009 | WO2009012588A1 Immunogenic polypeptides and monoclonal antibodies |
| 01/29/2009 | WO2009012574A1 Oxidation process |
| 01/29/2009 | WO2008149247A3 Kinetic determination of peracid and/or peroxide concentrations |
| 01/29/2009 | WO2008148522A3 Method to identify modulators of b-raf protein kinase and their use for the treatment of anxiety and depression |
| 01/29/2009 | WO2008146272A3 Compositions and methods for treating cxcr6/cxcl16 associated diseases |
| 01/29/2009 | WO2008131261A3 Peptide biomarkers of cardiovascular disease |
| 01/29/2009 | WO2008127680A3 Diagnosis and treatment of diseases caused by misfolded proteins |
| 01/29/2009 | WO2008122441A3 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases |
| 01/29/2009 | WO2008114204A3 A combined scalable in vitro differentiation system for human blastocyst-derived stem (hbs) cells or cells derived from hbs cells for direct assay application in multiwell plates |
| 01/29/2009 | WO2008110729A3 Method and system for stabilising an egg tray |
| 01/29/2009 | WO2008101177A3 Ige antibodies to chimeric or humanized igg therapeutic monoclonal antibodies as a screening test for anaphylaxis |
| 01/29/2009 | WO2008091294A3 Polymer nems for cell physiology and microfabricated cell positioning system for micro-biocalorimeter |
| 01/29/2009 | WO2008055242A4 Early detection of diabetes |
| 01/29/2009 | WO2008020180A3 Methods of increasing the sensitivity of cancer cells to dna damage |
| 01/29/2009 | WO2008010101A9 Antagonist antibody against epha2 for the treatment of cancer |
| 01/29/2009 | WO2007146378A3 Diagnostic apparatus |
| 01/29/2009 | WO2007095749A8 Cytotoxicity mediation of cells evidencing surface expression of trop-2 |
| 01/29/2009 | WO2007027957A3 Reagents for the detection of protein phosphorylation in leukemia signaling pathways |
| 01/29/2009 | WO2006045066A9 Labeled compounds for proteasome inhibition |
| 01/29/2009 | US20090031445 Methods to enhance plant trauma resistance |
| 01/29/2009 | US20090031441 Regulatory Genes for Plant Differentiation and Growth, and Use of the Same |
| 01/29/2009 | US20090031435 SMA Therapy and Cell Based Assay |
| 01/29/2009 | US20090031433 Methods for screening insecticides |
| 01/29/2009 | US20090030617 Biosensor Calibration System |
| 01/29/2009 | US20090030398 Device and method for preventing hypoglycemia |
| 01/29/2009 | US20090030065 Use of Pde1c and Inhibitors Thereof |
| 01/29/2009 | US20090030054 Cytoplasmic antigens for detection of candida |
| 01/29/2009 | US20090029935 Centrosomal proteins and secretion |
| 01/29/2009 | US20090029925 Interaction of bim with trim2, an e3 ubiquitin ligase |
| 01/29/2009 | US20090029919 Integrins; interleukins; antifertility agents |
| 01/29/2009 | US20090029908 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS |
| 01/29/2009 | US20090029873 Alzheimer's Disease-Specific Alterations of the Erk1/Erk2 Phosphorylation Ratio-Alzheimer's Disease-Specific Molecular Biomarkers (Adsmb) |
| 01/29/2009 | US20090029869 Surface modification, linker attachment, and polymerization methods |
| 01/29/2009 | US20090029866 Libraries of oligomers labeled with different tags |
| 01/29/2009 | US20090029484 Novel Hemopoietin Receptor Protein, NR12 |
| 01/29/2009 | US20090029483 Reagent for latex aggregation reaction and method for detecting target substance |
| 01/29/2009 | US20090029482 Functional particle, and method for separation of target substance using the same |
| 01/29/2009 | US20090029481 Method for separating target component using magnetic nanoparticles |
| 01/29/2009 | US20090029478 Detection of target molecules through interaction with probes |
| 01/29/2009 | US20090029477 Ultra High-Throughput Opti-Nanopore DNA Readout Platform |
| 01/29/2009 | US20090029476 Reaction vessel, analyzer, and method of analysis |
| 01/29/2009 | US20090029475 gas chromatography; high degree of reliability; integration times for the various compounds are adjusted according to the aging of the column |
| 01/29/2009 | US20090029474 Determining deposit formation tendencies for a plurality of fluid samples; optimized using combinatorial chemistry; efficient; determining oxidation stability |
| 01/29/2009 | US20090029473 Lipid profile as a biomarker for early detection of neurological disorders |
| 01/29/2009 | US20090029472 Apparatuses and media for drug elution and methods for making and using them |
| 01/29/2009 | US20090029455 Chimeric t1r1 taste receptor encoding nucleic acid sequences and vectors |
| 01/29/2009 | US20090029453 Microfluidic apparatus comprising a matrix defining an axial flow path; for use in detection of preferential biopolymers in solution; high throughput assay |
| 01/29/2009 | US20090029452 Using single test immunochromatographic strips to perform a fecal occult blood test; sample collection matrix being in communication with the sample and solvent application apertures of the front and rear panels; and an insertable test strip containing a reagent enabling detection of the analyte |
| 01/29/2009 | US20090029423 Method for separating target component |
| 01/29/2009 | US20090029415 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 01/29/2009 | US20090029406 Npy Y4 Agonist as Therapeutic Agent for Disease Accompanied by Intestinal Tract Dysfunction |
| 01/29/2009 | US20090029404 Modulation of aqueous humor outflow by targeting vascular-endothelial-cadherin in schlemm's canal cells |
| 01/29/2009 | US20090029400 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 01/29/2009 | US20090029397 Method for Monitoring Tocolytic Treatment |
| 01/29/2009 | US20090029396 Assay kit and antibody for human low molecular weight CD14 |
| 01/29/2009 | US20090029395 Methods for Detection of Chlamydia in Samples |
| 01/29/2009 | US20090029394 Novel Assay for the Detection of an Antibody Bound to a Cell Membrane Receptor |
| 01/29/2009 | US20090029393 Method for preparing antibodies selective for activating fc receptors |
| 01/29/2009 | US20090029392 Magnetic-nanoparticle conjugates and methods of use |
| 01/29/2009 | US20090029391 Reagents and methods for the determination of pk/adme-tox characteristics of new chemical entities and of drug candidates |
| 01/29/2009 | US20090029390 cAMP-responsive element binding protein (CBP); HIF-1 (hypoxia inducible factor-1); screening for inhibitors against the formation of HIF-1 alpha -p300 or HIF-1 alpha -CBP protein complexes |
| 01/29/2009 | US20090029389 Fluorescent metal ion indicators with large stokes shifts |
| 01/29/2009 | US20090029388 Detection of Antibodies |
| 01/29/2009 | US20090029387 Method for effectively measuring the activity of cytotoxic t lymphocytes in human and out-bred animals |
| 01/29/2009 | US20090029384 Techniques for recording signals |
| 01/29/2009 | US20090029382 Characterization of a membrane estrogen receptor |
| 01/29/2009 | US20090029380 HUMAN MutY |
| 01/29/2009 | US20090029378 High sensitivity multiparameter method for rare event analysis in a biological sample |
| 01/29/2009 | US20090029372 Adam12 as a biomarker for bladder cancer |
| 01/29/2009 | US20090029368 Method for determining the cell culture history of a cell unit labelled with more than one type of tag |
| 01/29/2009 | US20090029361 Growth differentiation factor-7 |
| 01/29/2009 | US20090029358 Methods and Compositions for the Diagnosis and Treatment of Schizophrenia |
| 01/29/2009 | US20090029357 Method for diagnosing cancer using cancer-associated deletion gene marker |
| 01/29/2009 | US20090029355 Abnormalities of Phosphatase 2A (PP2A) for Diagnosis and Treatment of Alzheimer's Disease |
| 01/29/2009 | US20090029353 Molecular detector |
| 01/29/2009 | US20090029351 Method of measuring human cyp3a inducibility |
| 01/29/2009 | US20090029350 Rapid diagnostic method for distinguishing allergies and infections and nasal secretion collection unit |
| 01/29/2009 | US20090029349 Chemiluminescence; quantitative analysis of macromolecules; complexing sample to acridinium compound, labels for improving sensitivity of immunoassays, 2',6'-dimethyl-4'-N-succinimidyloxycaproyl-amidocarbonylphenyl-N10-2,7-tris[O-methoxyhexa(ethylene) glycol-sulfonamidylpropyl]-acridinium-9-carboxylate |
| 01/29/2009 | US20090029347 Method for Identifying Multiple Analytes Using Flow Cytometry |
| 01/29/2009 | US20090029016 Method of Adjusting Temperatures of Products to Desired Product Temperatures |
| 01/29/2009 | US20090028968 Pharmaceutical Platform Technology for the Development of Natural Products |
| 01/29/2009 | US20090028901 use of such proteins in isolating various types of attenuated viruses for the development of vaccine and pharmaceutical formulations; protocols utilizing interferon antagonists, e.g., NS1, to enhance gene therapy or DNA vaccination based on their ability to increase gene expression |
| 01/29/2009 | US20090028893 Methods for producing fusion polypeptides or enhancing expression of fusion polypeptides |
| 01/29/2009 | US20090028891 Chlamydia Antigens and Uses Thereof |
| 01/29/2009 | US20090028888 Cancer Antigen Mage-A9 and Uses Thereof |
| 01/29/2009 | US20090028887 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/29/2009 | US20090028885 Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis specific autoantibodies, and the use thereof |
| 01/29/2009 | US20090028884 Oligomeric receptor ligand pair member complexes |